InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Dougherty Michael Philip. Director active across 1 company, notably bioAffinity Technologies, Inc.. Aggregated, 2 filings have been published. Activity tracked since 6 June 2023. The latest transaction was filed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations